On October 15, LuMind Foundation Executive Director Carolyn Cronin attended a research presentation by the Cure Alzheimer’s Fund at the Harvard Club in Boston.
The presentation featured Rudy Tanzi, Ph.D., of Harvard Medical School/Massachusetts General Hospital and chairman of Cure Alzheimer’s Fund Research Consortium, talking about the state of Alzheimer’s research today. For Carolyn, a lot of the discussion was about familiar territory.
“Dr. Tanzi’s presentation focused on the same parts of the brain – the hippocampus, frontal cortex, cerebellum – that we do in our Down syndrome research updates,” said Carolyn. “This meeting reinforced the reasons why we work in collaboration with those in the Alzheimer’s field. It’s exciting to think how those individuals in the Down syndrome community who are participating in clinical trials could benefit the Alzheimer’s community, too.”
“It was so interesting to see the correlation between the research LuMind Foundation is funding on Down syndrome cognition and the Alzheimer’s research,” said Carolyn. “It just proves you never know where the next research breakthrough will come or the impact it could have.”